179 related articles for article (PubMed ID: 19011184)
1. Role of PET in the initial staging of cutaneous malignant melanoma: systematic review.
Krug B; Crott R; Lonneux M; Baurain JF; Pirson AS; Vander Borght T
Radiology; 2008 Dec; 249(3):836-44. PubMed ID: 19011184
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of the diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography in melanoma patients.
Mijnhout GS; Hoekstra OS; van Tulder MW; Teule GJ; Devillé WL
Cancer; 2001 Apr; 91(8):1530-42. PubMed ID: 11301402
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma.
Jiménez-Requena F; Delgado-Bolton RC; Fernández-Pérez C; Gambhir SS; Schwimmer J; Pérez-Vázquez JM; Carreras-Delgado JL
Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):284-300. PubMed ID: 19727717
[TBL] [Abstract][Full Text] [Related]
4. Value of positron emission tomography scan in stage III cutaneous melanoma: a systematic review and meta-analysis.
Rodriguez Rivera AM; Alabbas H; Ramjaun A; Meguerditchian AN
Surg Oncol; 2014 Mar; 23(1):11-6. PubMed ID: 24556310
[TBL] [Abstract][Full Text] [Related]
5. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
[TBL] [Abstract][Full Text] [Related]
6. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
[TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma.
Macfarlane DJ; Sondak V; Johnson T; Wahl RL
J Clin Oncol; 1998 May; 16(5):1770-6. PubMed ID: 9586890
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of (18)F-FDG-PET/CT in early and late stages of high-risk cutaneous malignant melanoma.
Gellén E; Sántha O; Janka E; Juhász I; Péter Z; Erdei I; Lukács R; Fedinecz N; Galuska L; Remenyik É; Emri G
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1938-44. PubMed ID: 25753249
[TBL] [Abstract][Full Text] [Related]
9. FDG PET in early stage cutaneous malignant melanoma.
McIvor J; Siew T; Campbell A; McCarthy M
J Med Imaging Radiat Oncol; 2014 Apr; 58(2):149-54; quiz 266. PubMed ID: 24690243
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy.
Wagner JD; Schauwecker D; Davidson D; Coleman JJ; Saxman S; Hutchins G; Love C; Hayes JT
J Clin Oncol; 1999 May; 17(5):1508-15. PubMed ID: 10334538
[TBL] [Abstract][Full Text] [Related]
11. Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
Wagner T; Meyer N; Zerdoud S; Julian A; Chevreau C; Payoux P; Courbon F
Br J Dermatol; 2011 Jun; 164(6):1235-40. PubMed ID: 21332457
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.
Reinhardt MJ; Joe AY; Jaeger U; Huber A; Matthies A; Bucerius J; Roedel R; Strunk H; Bieber T; Biersack HJ; Tüting T
J Clin Oncol; 2006 Mar; 24(7):1178-87. PubMed ID: 16505438
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
Cheng X; Li Y; Liu B; Xu Z; Bao L; Wang J
Acta Radiol; 2012 Jul; 53(6):615-27. PubMed ID: 22734080
[TBL] [Abstract][Full Text] [Related]
14. F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review.
Schröer-Günther MA; Wolff RF; Westwood ME; Scheibler FJ; Schürmann C; Baumert BG; Sauerland S; Kleijnen J
Syst Rev; 2012 Dec; 1():62. PubMed ID: 23237499
[TBL] [Abstract][Full Text] [Related]
15. [Role of FDG PET-CT in cutaneous melanoma].
Nicol I; Chuto G; Gaudy-Marqueste C; Brenot-Rossi I; Grob JJ; Richard MA
Bull Cancer; 2008 Nov; 95(11):1089-101. PubMed ID: 19036682
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis of pretherapeutic lymph node staging of colorectal cancer by 18F-FDG PET or PET/CT.
Lu YY; Chen JH; Ding HJ; Chien CR; Lin WY; Kao CH
Nucl Med Commun; 2012 Nov; 33(11):1127-33. PubMed ID: 23000829
[TBL] [Abstract][Full Text] [Related]
17. Detection of metastases in patients with cutaneous melanoma using FDG-PET/CT.
Akcali C; Zincirkeser S; Erbagcý Z; Akcali A; Halac M; Durak G; Sager S; Sahin E
J Int Med Res; 2007; 35(4):547-53. PubMed ID: 17697533
[TBL] [Abstract][Full Text] [Related]
18. Clinical applications of fluorodeoxyglucose--positron emission tomography in the management of malignant melanoma.
Kumar R; Alavi A
Curr Opin Oncol; 2005 Mar; 17(2):154-9. PubMed ID: 15725921
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of fluorine 18 fluorodeoxyglucose positron emission tomography imaging for detection of primary lesion and staging of endometrial cancer patients: systematic review and meta-analysis of the literature.
Kakhki VR; Shahriari S; Treglia G; Hasanzadeh M; Zakavi SR; Yousefi Z; Kadkhodayan S; Sadeghi R
Int J Gynecol Cancer; 2013 Nov; 23(9):1536-43. PubMed ID: 24172090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
